SCHEMBL27932764

SCHEMBL27932764

Nc1cc(OB(O)O)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ CA14 Q9ULX7 1/20 0.47
▸ TSHR P16473 4/20 0.45
▸ TP53 P04637 1/20 0.45
▸ DRD4 P21917 1/20 0.39
▸ GAA P10253 2/20 0.37
▸ NR4A1 P22736 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31505704 1.00 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL2087980 0.81 HSP90AA1 (0.48) TSHRTP53KDM4EMEN1ALDH1A1
SCHEMBL28006279 0.79 HSP90AA1 (0.47) TSHRTP53KDM4EMEN1ALDH1A1
SCHEMBL30988470 0.78 HSD17B10 (0.46) CA12CA1CA2CA7CA9
SCHEMBL30844891 0.76 PPARG (0.42) MAPTALDH1A1KMT2ATDP1HSP90AA1
SCHEMBL29001084 0.76 ALDH1A1 (0.45) TSHRGAANR4A1KDM4EMAPT
SCHEMBL3367275 0.76 PPARG (0.42) MAPTALDH1A1KMT2ATDP1HSP90AA1
SCHEMBL30662001 0.76 ALDH1A1 (0.45) TSHRGAANR4A1KDM4EMAPT
SCHEMBL30078218 0.76 NR4A1 (0.35) GAANR4A1KDM4EMAPTMEN1
SCHEMBL10892274 0.76 CA12 (0.47) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111433204-A Process for the preparation of (3S) -3- (4-chloro-3- { [ (2S,3R) -2- (4-chlorophenyl) -4,4, 4-trifluoro-3-methylbutyryl ] amino } phenyl) -3-cyclopropylpropionic acid and crystalline forms thereof for use as a pharmaceutically active substance 拜耳制药股份公司 2020-07-17 — — CN disclosed
CN-103261186-A Dimeric IAP inhibitors NOVARTIS AG 2013-08-21 — — CN disclosed
Send feedback